ATHEROGENICS INC
S-1/A, EX-27.2, 2000-08-04
PHARMACEUTICAL PREPARATIONS
Previous: ATHEROGENICS INC, S-1/A, EX-27.1, 2000-08-04
Next: ATHEROGENICS INC, 8-A12G, 2000-08-04



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE MARCH
31, 1999 AND 2000 FINANCIAL STATEMENTS OF ATHEROGENICS, INC. AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               MAR-31-1999             MAR-31-2000
<CASH>                                               0              10,010,491
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0               2,049,600
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0              12,577,626
<PP&E>                                               0               2,844,994
<DEPRECIATION>                                       0              (1,196,422)
<TOTAL-ASSETS>                                       0              14,416,698
<CURRENT-LIABILITIES>                                0               4,773,548
<BONDS>                                              0                       0
                                0              39,604,288
                                          0                       0
<COMMON>                                             0              14,100,005
<OTHER-SE>                                           0             (44,503,732)
<TOTAL-LIABILITY-AND-EQUITY>                         0              14,416,698
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0               2,091,280
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                             2,628,092               5,643,840
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                             122,243                (157,767)
<INCOME-PRETAX>                             (2,750,335)             (3,394,793)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                         (2,750,335)             (3,394,793)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                (2,750,335)             (3,394,793)
<EPS-BASIC>                                      (1.14)                  (1.29)
<EPS-DILUTED>                                    (1.14)                  (1.29)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission